Prospective study on stereotactic body radiotherapy for small pancreatic neuroendocrine tumors: tolerance and effectiveness analysis
Clinical and Translational Oncology · 2024
DOI: 10.1007/s12094-024-03538-w ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical and Translational Oncology, 2024. Verfasst von Mercedes López Gonzalez und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Hospital Universitario HM Sanchinarro, HM Hospitales, Oña 10, 28050, Madrid, Spain. mlopez@hmhospitales.com. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Radiosurgery, Neuroendocrine Tumors. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 29 Literaturangaben.
Abstract (Originalsprache)
INTRODUCTION: Surgery is the standard treatment for pancreatic neuroendocrine tumors (pNETs), obtaining favorable results but associating high morbidity and mortality rates. This study assesses stereotactic body radiation therapy (SBRT) as a radical approach for small ( 2 toxicity. 40% showed morphological response, 55% remained stable. Metabolically, 50% achieved significant improvement. With a median OS of 41.5 months, all patients were alive without local or distant progression or need for surgical resection. CONCLUSION: SBRT is a feasible and well-tolerated approach for small neuroendocrine pancreatic tumors, demonstrating effective local control. Further investigations are vital for validation and extension of these findings.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiation Oncology, Hospital Universitario HM Sanchinarro, HM Hospitales, Oña 10, 28050, Madrid, Spain. mlopez@hmhospitales.com.
- Department of Radiation Oncology, Hospital Universitario HM Sanchinarro, HM Hospitales, Oña 10, 28050, Madrid, Spain.
- Department of Nuclear Medicine, Hospital Universitario HM Sanchinarro, HM Hospitales, Madrid, Spain.
- Department of Gastroenterology, Hospital Universitario HM Sanchinarro, HM Hospitales, Madrid, Spain.
- Department of Surgery, Hospital Universitario HM Sanchinarro, HM Hospitales, Madrid, Spain.
Zitieren
APA
López Gonzalez, M., Hernando-Requejo, O., Ciervide Jurío, R., Montero Luis, Á., Saiz Guisasola, C., Sánchez Saugar, E., Álvarez Rodríguez, B., Chen-Zhao, X., García-Aranda, M., Valero Albarran, J., Alonso Gutierrez, R., García Cañamaque, L., Prados, S., Quijano, Y., de Vicente, E., & Rubio, C. (2024). Prospective study on stereotactic body radiotherapy for small pancreatic neuroendocrine tumors: tolerance and effectiveness analysis. Clinical and Translational Oncology. https://doi.org/10.1007/s12094-024-03538-w
Vancouver
López Gonzalez M, Hernando-Requejo O, Ciervide Jurío R, Montero Luis Á, Saiz Guisasola C, Sánchez Saugar E, et al. Prospective study on stereotactic body radiotherapy for small pancreatic neuroendocrine tumors: tolerance and effectiveness analysis. Clinical and Translational Oncology. 2024. doi:10.1007/s12094-024-03538-w
BibTeX
@article{LpezGonzalez2024,
author = {López Gonzalez, Mercedes and Hernando-Requejo, Ovidio and Ciervide Jurío, Raquel and Montero Luis, Ángel and Saiz Guisasola, Carmen and Sánchez Saugar, Emilio and Álvarez Rodríguez, Beatriz and Chen-Zhao, Xin and García-Aranda, Mariola and Valero Albarran, Jeannette and Alonso Gutierrez, Rosa and García Cañamaque, Lina and Prados, Susana and Quijano, Yolanda and de Vicente, Emilio and Rubio, Carmen},
title = {Prospective study on stereotactic body radiotherapy for small pancreatic neuroendocrine tumors: tolerance and effectiveness analysis},
journal = {Clinical and Translational Oncology},
year = {2024},
doi = {10.1007/s12094-024-03538-w}
}
EUVIMED